Metal-organic frameworks (MOFs) as host materials for the enhanced delivery of biomacromolecular therapeutics

• Published in: Chemical communications (Cambridge, England) Vol. 57; no. 91; pp. 1298 - 1211
• Main Authors: Tong, Pei-Hong, Zhu, Ling, Zang, Yi, Li, Jia, He, Xiao-Peng, James, Tony D
• Format: Journal Article
• Language: English
• Published: England Royal Society of Chemistry 16.11.2021
• Subjects: Antibodies; Antigens; Biocompatibility; Biomedical materials; Chemical compounds; DNA; Drug Delivery Systems; Encapsulation; Gene therapy; Health services; humans; immunotherapy; Metal-organic frameworks; Metal-Organic Frameworks - chemistry; Oxidation; Pharmaceutical Preparations - chemistry; Pharmacology; Polypeptides; Polysaccharides; Pore size; porosity; RNA; starvation; Supramolecular compounds
• ISSN: 1359-7345; 1364-548X; 1364-548X
• DOI: 10.1039/d1cc05157a

Biomacromolecular drugs have become an important class of therapeutic agents for the treatment of human diseases. Considering their high propensity for being degraded in the human body, the choice of an appropriate delivery system is key to ensure the therapeutic efficacy of biomacromolecular drugs in vivo . As an emerging class of supramolecular "host" materials, metal-organic frameworks (MOFs) exhibit advantages in terms of the tunability of pore size, encapsulation efficiency, controllable drug release, simplicity in surface functionalization and good biocompatibility. As a result, MOF-based host-guest systems have been extensively developed as a new class of flexible and powerful platform for the delivery of therapeutic biomacromolecules. In this review, we summarize current research progress in the synthesis of MOFs as delivery materials for a variety of biomacromolecules. Firstly, we briefly introduce the advances made in the use of biomacromolecular drugs for disease therapy and the types of commonly used clinical delivery systems. We then describe the advantages of using MOFs as delivery materials. Secondly, the strategies for the construction of MOF-encapsulated biomacromolecules ( Biomacromolecules@MOFs ) and the release mechanisms of the therapeutics are categorized. Thirdly, the application of MOFs to deliver different types of biomacromolecules ( e.g. , antigens/antibodies, enzymes, therapeutic proteins, DNA/RNA, polypeptides, and polysaccharides) for the treatment of various human diseases based on immunotherapy, gene therapy, starvation therapy and oxidation therapy is summarized. Finally, the remaining challenges and available opportunities for MOFs as drug delivery systems are outlined, which we anticipate will encourage additional research efforts directed towards developing Biomacromolecules@MOFs systems for biomedical applications. We summarize recent progress in the enhanced delivery of biomacromolecular therapeutics for disease treatment using metal-organic frameworks (MOFs) as host materials.